HOME >> BIOLOGY >> NEWS
Glucose deficit affects young and old, could impact school schedules

CHAMPAIGN, Ill. Next time an older person says that thinking is exhausting, believe it. Concentration, researchers say, drains glucose from a key part of the brains of young and old rats, but dramatically more from older brains, which also take longer to recover. The findings, detailed in two studies published in May, are part of research that eventually may impact how schools schedule classes and meals as well as our understanding of age-related deficits in memory and learning, said lead researcher Paul E. Gold of the University of Illinois. "The brain runs on glucose," said Ewan C. McNay of Yale University. "Young rats can do a pretty good job of supplying all the glucose that a particular area of the brain needs until the task becomes difficult. For an old rat given the same task, the brain glucose supply vanishes out the window. This correlates with a big deficit in performance. A lack of fuel affects the ability to think and remember."

Glucose is a naturally occurring sugar in the blood and the primary source of energy in human brain metabolism. Last year, Gold, a professor of psychology, and McNay broke ground when they reported declines of hippocampal extracellular glucose concentrations in rats as they went through a maze. Their findings challenged conventional thinking about levels and stability of glucose in the brain. It has long been thought that the brain always has an ample supply of glucose short of starvation.

"While this is the case in terms of consciousness, the new findings suggest that glucose is not always present in ample amounts to optimally support learning and memory functions," said Gold, who also is director of the Medical Scholars Program in the UI College of Medicine at Urbana-Champaign.

In the May issue of Neurobiology of Learning and Memory, Gold, McNay and Richard C. McCarty, formerly at the University of Virginia, reported that glucose drainage during a task is site specific. Hippocampal extracellular levels fe
'"/>

Contact: Jim Barlow
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
3-Jun-2001


Page: 1 2

Related biology news :

1. Rare deficit maps thinking circuitry
2. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
3. Researchers target deficit irrigation for wine grapes
4. Lack of specific brain protein causes marked deficits in learning, memory
5. Gray matter damage in the brain of MS patients linked to cognitive, physical deficits
6. Adult alcoholism and attention-deficit hyperactivity disorder are connected
7. Rutgers researcher advances understanding of attention deficit disorder and schizophrenia
8. Is there a link between soy formula and attention deficit disorder?
9. ADHD in a SNAP: The SNAP gene in attention deficit hyperactivity
10. The immune system may be involved in the susceptibility to childhood attention deficit hyperactivity disorder (ADHD)
11. A stomach enzyme deficit may place women at more risk from drinking alcohol

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Glucose deficit affects young and old could impact school schedules

(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/26/2015)... TORONTO , March 26, 2015 ... premier family, social, recreation and athletic club, today announced ... designed to allow freedom of movement for members and ... "Following a comprehensive process, we selected FST,s IMID ... sophistication and convenience for our members and staff, in ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
(Date:4/20/2015)... British Columbia and MENLO ... --  DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar ... developing and commercializing proven cancer therapies in new ... at the 106th Annual Meeting of the ... Meeting on the potential for its lead product ...
(Date:4/20/2015)... , April 20, 2015  Eli Lilly and ... data from several targeted cancer therapies, reflecting Lilly,s diverse ... (AACR) Annual Meeting 2015, held April 18-22 in ... Cancer Discoveries to Patients" is the theme of this ... Lilly,s commitment to broadening its portfolio of therapies that ...
(Date:4/20/2015)... --  Meditope Biosciences, Inc ., a biotechnology company developing ... presentation of data demonstrating the use of its SnAP ... data were presented in an abstract at the AACR ... Philadelphia . "We are ... many commercial applications that may be possible for our ...
(Date:4/17/2015)... Reed Technology and Information Services Inc. ... and submission to the U.S. Food and Drug Administration ... Distribution Report (LDR) service for manufacturers of biologics, including ... FDA’s new rule on electronic submission of LDRs. ... and timing of particular biologics introduced to the marketplace, ...
Breaking Biology Technology:DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3
Cached News: